Viruses (Sep 2024)

Protection Evaluation of a New Attenuated ASFV by Deletion of the <i>L60L</i> and <i>CD2v</i> Genes against Homologous Challenge

  • Jinjin Yang,
  • Rongnian Zhu,
  • Nan Li,
  • Yanyan Zhang,
  • Xintao Zhou,
  • Huixian Yue,
  • Qixuan Li,
  • Yu Wang,
  • Faming Miao,
  • Teng Chen,
  • Fei Zhang,
  • Shoufeng Zhang,
  • Aidong Qian,
  • Rongliang Hu

DOI
https://doi.org/10.3390/v16091464
Journal volume & issue
Vol. 16, no. 9
p. 1464

Abstract

Read online

African swine fever (ASF) is an acute infectious disease with a high mortality rate in both domestic and wild boars. Commercial vaccines or antiviral drugs for ASF were not available due to the complex diversity of the structure and genome of its pathogen African swine fever virus (ASFV). In recent years, there have been many reports on candidate strains of attenuated vaccines for ASFV. In this study, we obtained a recombinant virus named SY18ΔL60LΔCD2v by simultaneously deleting the L60L gene and CD2v gene from highly virulent strain SY18. In vitro, SY18ΔL60LΔCD2v displayed a decreased growth kinetic compared to that of parental SY18. In vivo, high doses (105 TCID50) of SY18ΔL60LΔCD2v can protect pigs (5/5) from attacks by the parental SY18 strain (102 TCID50). Low doses (102 TCID50) of SY18ΔL60LΔCD2v only protected 20% of pigs (1/5) from attacks by the parental SY18 strain (102 TCID50). The results indicated that the absence of these two genes in SY18 could induce protection against the homologous parental strain, and there were no obvious clinical symptoms or viremia. These results indicate that the SY18ΔL60LΔCD2v strain can serve as a new live attenuated vaccine candidate for the prevention and control of ASFV infection.

Keywords